The biological basis of injury and neuroprotection in the fetal and neonatal brain

International Journal of Developmental Neuroscience

Volumn 29, Issue 6, 2011, Pages 551-563

  Rees, Sandra ^a   Harding, Richard ^b   Walker, David ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Developmental brain injury; Inflammation; Intrauterine growth restriction; Neuroprotective agents; Prenatal hypoxia; White matter damage

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ACETYLCYSTEINE; CREATININE; ELTANOLONE; MAGNESIUM SULFATE; MELATONIN; NEUROSTEROID; PROGESTERONE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AUDITORY SYSTEM; BRAIN CORTEX; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN HYPOXIA; BRAIN INJURY; CEREBELLUM; CHRONIC LUNG DISEASE; CLINICAL TRIAL (TOPIC); CONGENITAL CREATININE DEFICIENCY; CONTINUOUS INFUSION; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; DRUG SAFETY; ENCEPHALITIS; FETAL MALNUTRITION; FETOPLACENTAL UNIT; FETUS; FETUS HYPOXIA; GESTATIONAL AGE; HIPPOCAMPUS; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; INTRAUTERINE GROWTH RETARDATION; METABOLIC DISORDER; NERVE CELL NECROSIS; NERVE CELL NETWORK; NEURAL STEM CELL TRANSPLANTATION; NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN; NONHUMAN; NUTRITIONAL DEFICIENCY; OXYGEN SATURATION; PERINATAL ASPHYXIA; PLACENTA INSUFFICIENCY; POSTNATAL DEVELOPMENT; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; VISUAL SYSTEM; WHITE MATTER;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; FETAL DISEASES; FETUS; HUMANS; HYPOXIA, BRAIN; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MATERNAL-FETAL RELATIONS; PREGNANCY;

ANIMALIA; PAPIO;

EID: 80052396423     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.04.004     Document Type: Article

References (176)

1. Aher S., Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Review). Cochrane Database Syst. Rev. 2006, 3:CD004868.
2. Ahola T., Lapatto R., Raivio K.O., Selander B., Stigson L., Jonsson B., et al. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial. J. Pediatr. 2003, 143:713-719.
3. Allin M., Matsumoto H., Santhouse A.M., Nosarti C., AlAsady M.H., Stewart A.L., et al. Cognitive and motor function and the size of the cerebellum in adolescents born very pre-term. Brain 2001, 124:60-66.
4. Allin M., Walshe M., Fern A., Nosarti C., Cuddy M., Rifkin L., et al. Cognitive maturation in preterm and term born adolescents. J. Neurol. Neurosurg. Psychiatr. 2008, 79:381-386.
5. Andiman S.E., Haynes R.L., Trachtenberg F.L., Billiards S.S., Folkerth R.D., Volpe J.J., et al. The cerebral cortex overlying periventricular leukomalacia: analysis of pyramidal neurons. Brain Pathol. 2010, 20:803-814.
6. Azzopardi D.V., Strohm B., Edwards A.D., Dyet L., Halliday H.L., Juszczak E., et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N. Engl. J. Med. 2009, 361:1349-1358.
7. Back S.A., Craig A., Kayton R.J., Luo N.L., Meshul C.K., Allcock N., et al. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J. Cereb. Blood Flow Metab. 2007, 27:334-347.
8. Back S.A., Gan X., Li Y., Rosenberg P.A., Volpe J.J. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 1998, 18:6241-6253.
9. Back S.A., Luo N.L., Mallinson R.A., O'Malley J.P., Wallen L.D., Frei B., et al. Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann. Neurol. 2005, 58:108-120.
10. Back S.A., Riddle A., Hohimer A.R. Role of instrumented fetal sheep preparations in defining the pathogenesis of human periventricular white-matter injury. J. Child Neurol. 2006, 21:582-589.
11. Badawi N., Kurinczuk J.J., Keogh J.M., Alessandri L.M., O'Sullivan F., Burton P.R., et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998, 317:1549-1553.
12. Battini R., Alessandrì M.G., Leuzzi V., Moro F., Tosetti M., Bianchi M.C., et al. Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J. Pediatr. 2006, 148:828-830.
13. Beloosesky R., Gayle D.A., Amidi F., Nunez S.E., Babu J., Desai M., et al. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am. J. Obstet. Gynecol. 2006, 194:268-273.
14. Bianchi M.C., Tosetti M., Fornai F., Grazia Alessandri M., Cipriani P., De Vito G., et al. Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann. Neurol. 2000, 47:511-513.
15. Bierer R., Peceny M.C., Hartenberger C.H., Ohls R.K. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006, 118:e635-e640.
16. Billiards S.S., Haynes R.L., Folkerth R.D., Borenstein N.S., Trachtenberg F.L., Rowitch D.H., et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 2008, 18:153-163.
17. Blair E., Stanley F.J. Intrapartum asphyxia: a rare cause of cerebral palsy. J. Pediatr. 1988, 112:515-519.
18. Blood A.B., Hunter C.J., Power G.G. Adenosine mediates decreased cerebral metabolic rate and increased cerebral blood flow during acute moderate hypoxia in the near-term fetal sheep. J. Physiol. 2003, 553:935-945.
19. Bocking A.D., Gagnon R., White S.E., Homan J., Milne K.M., Richardson B.S. Circulatory responses to prolonged hypoxemia in fetal sheep. Am. J. Obstet. Gynecol. 1988, 159:1418-1424.
20. Brewer G.J., Wallimann T.W. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J. Neurochem. 2000, 74:1968-1978.
21. Broad A., Jones D.E., Kirby J.A. Toll-like receptor (TLR) response tolerance: a key physiological 'damage limitation' effect and an important potential opportunity for therapy. Curr. Med. Chem. 2006, 13:2487-2502.
22. Brosnan J.T., Brosnan M.E. Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu. Rev. Nutr. 2007, 27:241-261.
23. Brown M.S., Eichorst D., Lala-Black B., Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics 2009, 124:e681-e687.
24. Bui B.V., Rees S.M., Loeliger M., Caddy J., Rehn A.H., Armitage J.A., et al. Altered retinal function and structure after chronic placental insufficiency. Invest. Ophthalmol. Vis. Sci. 2002, 43:805-812.
25. Campana W.M., Myers R.R. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J. 2001, 15:1804-1806.
26. Castillo-Melendez M., Chow J.A., Walker D.W. Lipid peroxidation caspase-3 immunoreactivity, and pyknosis in late-gestation fetal sheep brain after umbilical cord occlusion. Pediatr. Res. 2004, 55:864-871.
27. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
28. Cilio M.R., Ferriero D.M. Synergistic neuroprotective therapies with hypothermia. Semin. Fetal Neonatal Med. 2010, 15:293-298.
29. Coalson J.J., Winter V.T., Siler-Khodr T., Yoder B.A. Neonatal chronic lung disease in extremely immature baboons. Am. J. Respir. Crit. Care Med. 1999, 160:1333-1346.
30. Cowan F., Rutherford M., Groenendaal F., Eken P., Mercuri E., Bydder G.M., et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 2003, 361:736-742.
31. Dalitz P., Harding R., Rees S.M., Cock M.L. Prolonged reductions in placental blood flow and cerebral oxygen delivery in preterm fetal sheep exposed to endotoxin: possible factors in white matter injury after acute infection. J. Soc. Gynecol. Investig. 2003, 10:283-290.
32. Dammann O., Hagberg H., Leviton A. Is periventricular leukomalacia an axonopathy as well as an oligopathy?. Pediatr. Res. 2001, 49:453.
33. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr. Res. 1997, 42:1-8.
34. Deguchi K., Mizuguchi M., Takashima S. Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr. Neurol. 1996, 14:13-16.
35. Demers E.J., McPherson R.J., Juul S.E. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr. Res. 2005, 58:297-301.
36. Derrick M., Drobyshevsky A., Ji X., Tan S. A model of cerebral palsy from fetal hypoxia-ischemia. Stroke 2007, 38:731-735.
37. Derrick M., Luo N.L., Bregman J.C., Jilling T., Ji X., Fisher K., et al. Preterm fetal hypoxia-ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy?. J. Neurosci. 2004, 24:24-34.
38. Dieni S., Inder T., Yoder B., Briscoe T., Camm E., Egan G., et al. The pattern of cerebral injury in a primate model of preterm birth and neonatal intensive care. J. Neuropathol. Exp. Neurol. 2004, 63:1297-1309.
39. Dieni S., Rees S. BDNF and TrkB protein expression is altered in the fetal hippocampus but not cerebellum after chronic prenatal exposure. Exp. Neurol. 2005, 192:265-273.
40. Dijkstra F., Jozwiak M., De Matteo R., Duncan J., Hale N., Harding R., et al. Erythropoietin ameliorates damage to the placenta and fetal liver induced by exposure to lipopolysaccharide. Placenta 2010, 31:282-288.
41. Dowdeswell H.J., Slater A.M., Broomhall J., Tripp J. Visual deficits in children born at less than 32 weeks' gestation with and without major ocular pathology and cerebral damage. Br. J. Ophthalmol. 1995, 79:447-452.
42. Doyle L.W., Crowther C., Middleton P., Marret S. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet. Gynecol. 2009, 113:1327.
43. Duncan J.R., Camm E., Loeliger M., Cock M.L., Harding R., Rees S.M. Effects of umbilical cord occlusion in late gestation on the ovine fetal brain and retina. J. Soc. Gynecol. Investig. 2004, 11:369-376.
44. Duncan J.R., Cock M.L., Loeliger M., Louey S., Harding R., Rees S.M. Effects of exposure to chronic placental insufficiency on the postnatal brain and retina in sheep. J. Neuropathol. Exp. Neurol. 2004, 63:1131-1143.
45. Duncan J.R., Cock M.L., Scheerlinck J.P., Westcott K.T., McLean C., Harding R., et al. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr. Res. 2002, 52:941-949.
46. Duncan J.R., Cock M.L., Suzuki K., Scheerlinck J.P., Harding R., Rees S.M. Chronic endotoxin exposure causes brain injury in the ovine fetus in the absence of hypoxemia. J. Soc. Gynecol. Investig. 2006, 13:87-96.
47. Edwards A.D., Brocklehurst P., Gunn A.J., Halliday H., Juszczak E., Levene M., et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010, 340:c363.
48. Eklind S., Mallard C., Leverin A.L., Gilland E., Blomgren K., Mattsby-Baltzer I., et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur. J. Neurosci. 2001, 13:1101-1106.
49. Fauchere J.C., Dame C., Vonthein R., Koller B., Arri S., Wolf M., et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 2008, 122:375-382.
50. Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci. 2000, 20:34-42.
51. Ferrante R.J., Andreassen O.A., Jenkins B.G., Dedeoglu A., Kuemmerle S., Kubilus J.K., et al. Neuroprotective effects of creatine in a transgenic mouse model of huntington's disease. J. Neurosci. 2000, 20:4389-4397.
52. Fulia F., Gitto E., Cuzzocrea S., Reiter R.J., Dugo L., Gitto P., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J. Pineal Res. 2001, 31:343-349.
53. Garnier Y., Coumans A., Berger R., Jensen A., Hasaart T.H. Endotoxemia severely affects circulation during normoxia and asphyxia in immature fetal sheep. J. Soc. Gynecol. Investig. 2001, 8:134-142.
54. Genc K., Genc S., Baskin H., Semin I. Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes. Physiol. Res. 2006, 55:33.
55. Gitto E., Pellegrino S., Gitto P., Barberi I., Reiter R.J. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J. Pineal Res. 2009, 46:128-139.
56. Gluckman P.D., Wyatt J.S., Azzopardi D., Ballard R., Edwards A.D., Ferriero D.M., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005, 365:663-670.
57. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N. Engl. J. Med. 2000, 342:1500-1507.
58. Gorio A., Gokmen N., Erbayraktar S., Yilmaz O., Madaschi L., Cichetti C., et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:9450-9455.
59. Gunn A.J., Bennet L. Timing of injury in the fetus and neonate. Curr. Opin. Obstet. Gynecol. 2008, 20:175.
60. Gunn A.J., Bennet L., Gunning M., Gluckman P., Gunn T.R. Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep. Pediatr. Res. 1999, 46:274.
61. Haynes R.L., Billiards S., Borenstein N., Volpe J., Kinney H. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr. Res. 2008, 63:656.
62. Haynes R.L., Folkerth R.D., Keefe R.J., Sung I., Swzeda L.I., Rosenberg P.A., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J. Neuropathol. Exp. Neurol. 2003, 62:441-450.
63. He J., Hoffman S.W., Stein D.G. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor. Neurol. Neurosci. 2004, 22:19.
64. Heyes M.P., Achim C.L., Wiley C.A., Major E.O., Saito K., Markey S.P. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 1996, 320:595-597.
65. Holling E.E., Leviton A. Characteristics of cranial ultrasound white-matter echolucencies that predict disability: a review. Dev. Med. Child Neurol. 1999, 41:136-139.
66. Hopkins R., Lewis S. Structural imaging findings and macroscopic pathology. The Neuropathology of Schizophrenia 2000, 5-56. Oxford University Press, Oxford. P.J. Harrison, G.W. Roberts (Eds.).
67. Hutton L.C., Abbass M., Dickinson H., Ireland Z., Walker D. Neuroprotective properties of melatonin in a model of birth asphyxia in the spiny mouse (Acomys cahirinus). Dev. Neurosci. 2009, 31:437.
68. Hutton L.C., Castillo-Melendez M., Smythe G.A., Walker D.W. Microglial activation, macrophage infiltration, and evidence of cell death in the fetal brain after uteroplacental administration of lipopolysaccharide in sheep in late gestation. Am. J. Obstet. Gynecol. 2008, 198:117.e1-117.e11.
69. Hutton L.C., Ratnayake U., Shields A., Walker D. Neuropathology and functional deficits in a model of birth asphyxia in the precocial spiny mouse (Acomys cahirinus). Dev. Neurosci. 2009, 31:523-535.
70. Inder T.E., Anderson N.J., Spencer C., Wells S., Volpe J.J. White matter injury in the premature infant: a comparison between serial cranial sonographic and MR findings at term. Am. J. Neuroradiol. 2003, 24:805-809.
71. Inder T.E., Warfield S.K., Wang H., Huppi P.S., Volpe J.J. Abnormal cerebral structure is present at term in premature infants. Pediatrics 2005, 115:286-294.
72. Ireland Z., Dickinson H., Fleiss B., Hutton L.C., Walker D.W. Behavioural effects of near-term acute fetal hypoxia in a small precocial animal, the spiny mouse (Acomys cahirinus). Neonatology 2010, 97:45-51.
73. Ireland Z., Dickinson H., Snow R., Walker D.W. Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys cahirinus)?. Am. J. Obstet. Gynecol. 2008, 198:431.e1-431.e6.
74. Ireland Z., Russell A., Wallimann T., Walker D., Snow R. Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. BMC Dev. Biol. 2009, 9:39.
75. Isaacs E.B., Lucas A., Chong W.K., Wood S.J., Johnson C.L., Marshall C., et al. Hippocampal volume and everyday memory in children of very low birth weight. Pediatr. Res. 2000, 47:713-720.
76. Iwata O., Iwata S., Bainbridge A., De Vita E., Matsuishi T., Cady E.B., et al. Supra- and sub-baseline phosphocreatine recovery in developing brain after transient hypoxia-ischaemia: relation to baseline energetics, insult severity and outcome. Brain 2008, 131:2220-2226.
77. Iwata S., Bainbridge A., Nakamura T., Tamura M., Takashima S., Matsuishi T., et al. Subtle white matter injury is common in term-born infants with a wide range of risks. Int. J. Develop. Neurosci. 2010, 28:573-580.
78. Jatana M., Singh I., Singh A.K., Jenkins D. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res. 2006, 59:684.
79. Jensen E.C., Bennet L., Hunter C.J., Power G.C., Gunn A.J. Post-hypoxic hypoperfusion is associated with suppression of cerebral metabolism and increased tissue oxygenation in near-term fetal sheep. J. Physiol. 2006, 572:131-139.
80. Johnston B.M., Mallard E.C., Williams C.E., Gluckman P.D. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J. Clin. Invest. 1996, 97:300-308.
81. Johnston M.V., Trescher W.H., Ishida A., Nakajima W. Novel treatments after experimental brain injury. Semin. Neonatol. 2000, 5:75-86.
82. Johnstone E., Frith C.D., Crow T.J., Husband J., Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976, 308:924-926.
83. Juul S.E., McPherson R.J., Bauer L.A., Ledbetter K.J., Gleason C.A., Mayock D.E. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008, 122:383-391.
84. Kadhim H., Tabarki B., Verellen G., De Prez C., Rona A.-M., Sébire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278.
85. Kawakami M., Sekiguchi M., Sato K., Kozaki S., Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 2001, 276:39469-39475.
86. Kelleher M.A., Palliser H.K., Walker D.W., Hirst J.J. Sex-dependent effect of a low neurosteroid environment and intrauterine growth restriction on fetal guinea pig brain development. J. Endocrinol. 2011, 208:301-309.
87. Kendall G., Peebles D. Acute fetal hypoxia: the modulating effect of infection. Early Hum. Dev. 2005, 81:27-34.
88. Kinney H., Panigrahy A., Newburger J., Jonas R., Sleeper L. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiac surgery. Acta Neuropathol. 2005, 110:563-578.
89. Larroque B., Ancel P.-Y., Marret S., Marchand L., André M., Arnaud C., et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008, 371:813-820.
90. Lee J., Croen L.A., Lindan C., Nash K.B., Yoshida C.K., Ferriero D.M., et al. Predictors of outcome in perinatal arterial stroke: a population-based study. Ann. Neurol. 2005, 58:303-308.
91. Leviton A., Dammann O. Brain damage markers in children. Neurobiological and clinical aspects. Acta pædiatr. 2002, 91:9-13.
92. Ligam P., Haynes R.L., Folkerth R., Liu L., Yang M., Volpe J., et al. Thalamic damage in periventricular leukomalacia: novel pathologic observations relevant to cognitive deficits in survivors of prematurity. Pediatr. Res. 2009, 65:524-529.
93. Loeliger M., Inder T., Cain S., Ramesh R.C., Camm E., Thomson M.A., et al. Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure. Pediatrics 2006, 118:1640-1653.
94. Loeliger M., Inder T.E., Dalitz P.A., Cain S., Camm E.J., Yoder B., et al. Developmental and neuropathological consequences of ductal ligation in the preterm baboon. Pediatr. Res. 2008, 65:209-214.
95. Loeliger M., Mackintosh A., De Matteo R., Harding R., Rees S.M. Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury. Invest. Ophthalmol. Vis. Sci. 2011, 52:2656-2661.
96. Loeliger M., Watson C.S., Reynolds J.D., Penning D.H., Harding R., Bocking A.D., et al. Extracellular glutamate levels and neuropathology in cerebral white matter following repeated umbilical cord occlusion in the near term fetal sheep. Neuroscience 2003, 116:705-714.
97. Loeliger M.M., Briscoe T., Rees S.M. BDNF increases survival of retinal dopaminergic neurons after prenatal compromise. Invest. Ophthalmol. Vis. Sci. 2008, 49:1282-1289.
98. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999, 319:1054-1059.
99. Mallard C., Welin A.K., Peebles D., Hagberg H., Kjellmer I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem. Res. 2003, 28:215-223.
100. Mallard E.C., Rees S., Stringer M., Cock M.L., Harding R. Effects of chronic placental insufficiency on brain development in fetal sheep. Pediatr. Res. 1998, 43:262-270.
101. Mallard E.C., Rehn A., Rees S., Tolcos M., Copolov D. Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophrenia. Schiz. Res. 1999, 40:11-21.
102. Mann J.R., McDermott S., Bao H., Bersabe A. Maternal genitourinary infection and risk of cerebral palsy. Dev. Med. Child Neurol. 2009, 51:282-288.
103. Manuelpillai U., Ligam P., Smythe G., Wallace E.M., Hirst J., Walker D.W. Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: up-regulation by inflammatory stimuli and with clinical infection. Am. J. Obstet. Gynecol. 2005, 192:280-288.
104. Manuelpillai U., Nicholls T., Wallace E., Phillips D., Guillemin G., Walker D. Increased mRNA expression of kynurenine pathway enzymes in human placentae exposed to bacterial endotoxin. Adv. Exp. Med. Biol. 2003, 527:85-89.
105. Martinez-Estrada O.M., Rodriguez-Millan E., Gonzalez-de Vicente E., Reina M., Vilaro S., Fabre M. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur. J. Neurosci. 2003, 18:2538-2544.
106. McKendry A.A., Palliser H.K., Yates D.M., Walker D.W., Hirst J.J. The effect of betamethasone treatment on neuroactive steroid synthesis in a foetal guinea pig model of growth restriction. J. Neuroendocrinol. 2010, 22:166-174.
107. McPherson R.J., Juul S.E. Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr. Opin. Pediatr. 2010, 22:139-145.
108. Melcangi R., Garcia-Segura L., Mensah-Nyagan A. Neuroactive steroids: state of the art and new perspectives. Cell. Moll. Life Sci. 2008, 65:777-797.
109. Mellon S.H. Neurosteroid regulation of central nervous system development. Pharmacol. Ther. 2007, 116:107-124.
110. Miller S.L., Yan E., Castillo-Melendez M., Jenkins B.G., Walker D.W. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev. Neurosci. 2005, 27:200.
111. Nelson K.B. Causative factors in cerebral palsy. Clin. Obstet. Gynecol. 2008, 51:749.
112. Nguyen P.N., Billiards S.S., Walker D.W., Hirst J.J. Changes in 5[alpha]-pregnane steroids and neurosteroidogenic enzyme expression in the perinatal sheep. Pediatr. Res. 2003, 53:956-964.
113. Nicholls T., Lacey B., Nitsos I., Smythe G., Walker D.W. Regional changes in kynurenic acid, quinolinic acid, and glial fibrillary acidic protein concentrations in the fetal sheep brain after experimentally induced placental insufficiency. Am. J. Obstet. Gynecol. 2001, 184:203-208.
114. Nitsos I., Rees S. The effects of intrauterine growth retardation on the development of neuroglia in fetal guinea pigs. An immunohistochemical and an ultrastructural study. Int. J. Dev. Neurosci. 1990, 8:233-244.
115. Nitsos I., Rees S.M., Duncan J., Kramer B.W., Harding R., Newnham J.P., et al. Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. J. Soc. Gynecol. Investig. 2006, 13:239-247.
116. Northington F.J. Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. ILAR J. 2006, 47:32.
117. Ohls R.K., Ehrenkranz R.A., Das A., Dusick A.M., Yolton K., Romano E., et al. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004, 114:1287-1291.
118. Ozturk E., Demirbilek S., Kadir But A., Saricicek V., Gulec M., Akyol O., et al. Antioxidant properties of propofol and erythropoietin after closed head injury in rats. Prog. NeuroPsychopharmacol. Biol. Psychiatry 2005, 29:922-927.
119. Pearce W. Hypoxic regulation of the fetal cerebral circulation. J. Appl. Physiol. 2006, 100:731-738.
120. Peebles D.M., Marlow N., Brocklehurst P. Antenatal magnesium sulphate. BMJ 2010, 341:c6004.
121. Penning D.H., Grafe M.R., Hammond R., Matsuda Y., Patrick J., Richardson B. Neuropathology of the near-term and midgestation ovine fetal brain after sustained in utero hypoxemia. Am. J. Obstet. Gynecol. 1994, 170:1425-1432.
122. Petratos S., Hirst J.J., Mendis S., Anikijenko P., Walker D.W. Localization of P450scc and 5[alpha]-reductase type-2 in the cerebellum of fetal and newborn sheep. Brain Res. Dev. Brain Res. 2000, 123:81-86.
123. Pierson C., Folkerth R., Billiards S., Trachtenberg F., Drinkwater M., Volpe J., et al. Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol. 2007, 114:619-631.
124. Platt M.J., Cans C., Johnson A., Surman G., Topp M., Torrioli M.G., et al. Trends in cerebral palsy among infants of very low birthweight (<1500g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 2007, 369:43-50.
125. Prass K., Royl G., Lindauer U., Freyer D., Megow D., Dirnagl U., et al. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J. Cereb. Blood Flow Metab. 2006, 27:452-459.
126. Prass K., Royl G., Lindauer U., Freyer D., Megow D., Dirnagl U., et al. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J. Cereb. Blood Flow Metab. 2007, 27:452-459.
127. Probyn M.E., Cock M.L., Duncan J.R., Tolcos M., Hale N., Shields A., et al. The anti-inflammatory agent N-acetyl cysteine exacerbates endotoxin-induced hypoxemia and hypotension and induces polycythemia in the ovine fetus. Neonatology 2010, 98:118.
128. Rees S., Bocking A.D., Harding R. Structure of the fetal sheep brain in experimental growth retardation. J. Dev. Physiol. 1988, 10:211-225.
129. Rees S., Breen S., Loeliger M., McCrabb G., Harding R. Hypoxemia near mid-gestation has long-term effects on fetal brain development. J. Neuropathol. Exp. Neurol. 1999, 58:932-945.
130. Rees S., Hale N., De Matteo R., Cardamone L., Tolcos M., Loeliger M., et al. Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury. J. Neuropathol. Exp. Neurol. 2010, 69:306-319.
131. Rees S., Harding R. The effects of intrauterine growth retardation on the development of the Purkinje cell dendritic tree in the cerebellar cortex of fetal sheep: a note on the ontogeny of the Purkinje cell. Int. J. Develop. Neurosci. 1988, 6:461-469.
132. Rees S., Stringer M., Just Y., Hooper S.B., Harding R. The vulnerability of the fetal sheep brain to hypoxemia at mid-gestation. Brain Res. Dev. Brain Res. 1997, 103:103-118.
133. Rehn A.E., Loeliger M., Hardie N.A., Rees S.M., Dieni S., Shepherd R.K. Chronic placental insufficiency has long-term effects on auditory function in the guinea pig. Hear. Res. 2002, 166:159-165.
134. Rehn A.E., Van Den Buuse M., Copolov D., Briscoe T., Lambert G., Rees S. An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia. Neuroscience 2004, 129:381-391.
135. Reiter R., Tan D.-x., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. J. Biomed. Sci. 2000, 7:444-458.
136. Riddle A., Ling Luo N., Manese M., Beardsley D.J., Green L., Rorvik D.A., et al. Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J. Neurosci. 2006, 26:3045-3055.
137. Robertson N.J., Cowan F.M., Cox I.J., Edwards A.D. Brain alkaline intracellular pH after neonatal encephalopathy. Ann. Neurol. 2002, 52:732-742.
138. Roka A., Melinda K.T., Vasarhelyi B., Machay T., Azzopardi D., Szabo M. Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics 2008, 121:e844-e849.
139. Romero R., Chaiworapongsa T., Espinoza J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J. Nutr. 2003, 133:1668S-1673S.
140. Romero R., Gotsch F., Pineles B., Kusanovic J.P. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr. Rev. 2007, 65:S194-S202.
141. Saadani-Makki F., Kannan S., Lu X., Janisse J., Dawe E., Edwin S., et al. Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am. J. Obstet. Gynecol. 2008, 199:651.e1-651.e7.
142. Salafia C.M., Minior V.K., Lopez-Zeno J.A., Whittington S.S., Pezzullo J.C., Vintzileos A.M. Relationship between placental histologic features and umbilical cord blood gases in preterm gestations. Am. J. Obstet. Gynecol. 1995, 173:1058-1064.
143. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
144. Sato Y., Nakanishi K., Hayakawa M., Kakizawa H., Saito A., Kuroda Y., et al. Reduction of brain injury in neonatal hypoxic-ischemic rats by intracerebroventricular injection of neural stem/progenitor cells together with chondroitinase ABC. Reprod. Sci. 2008, 15:613-620.
145. Schulze A. Creatine deficiency syndromes. Mol. Cell. Biochem. 2003, 244:143-150.
146. Shankaran S., Laptook A.R., Ehrenkranz R.A., Tyson J.E., McDonald S.A., Donovan E.F., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 2005, 353:1574-1584.
147. Shatrov J.G., Birch S.C.M., Lam L.T., Quinlivan J.A., McIntyre S., Mendz G.L. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet. Gynecol. 2010, 116:387.
148. Siren A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4044-4049.
149. Sola A., Wen T.C., Hamrick S.E., Ferriero D.M. Potential for protection and repair following injury to the developing brain: a role for erythropoietin?. Pediatr. Res. 2005, 57:110R-117R.
150. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 2008, 57:386-397.
151. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 1993, 45:309-379.
152. Stys P.K., Waxman S.G., Ransom B.R. Reverse operation of the Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian CNS white matter. Ann. N Y Acad. Sci. 1991, 639:328-332.
153. Sun Y., Calvert J.W., Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005, 36:1672-1678.
154. Szymonowicz W., Walker A.M., Yu V.Y.H., Stewart M.L., Cannata J., Cussen L. Regional cerebral blood flow after hemorrhagic hypotension in the preterm, near-term, and newborn lamb. Pediatr. Res. 1990, 28:361-366.
155. Thomas W., Speer C.P. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome. Neonatology 2011, 99:177-187.
156. Torres-Farfan C., Valenzuela F.J., Mondaca M., Valenzuela G.J., Krause B., Herrera E.A., et al. Evidence of a role for melatonin in fetal sheep physiology: direct actions of melatonin on fetal cerebral artery, brown adipose tissue and adrenal gland. J. Physiol. 2008, 586:4017-4027.
157. Volpe J.J. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 2005, 116:221-225.
158. Volpe J.J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009, 8:110-124.
159. Wang L., Zhang Z., Wang Y., Zhang R., Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004, 35:1732-1737.
160. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
161. Welch K.M., Levine S.R., Helpern J.A. Pathophysiological correlates of cerebral ischemia the significance of cellular acid base shifts. Funct. Neurol. 1990, 5:21-31.
162. Welin A.-K., Svedin P., Lapatto R., Sultan B.O., Hagberg H., Gressens P., et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr. Res. 2007, 61:153-158. 10.1203/01.pdr.0000252546.20451.1a.
163. Williams C., Gunn A.J., Mallard C., Gluckman P. Outcome after ischaemia in the developing sheep brain: an electroencephalographic and histological study. Ann. Neurol. 1992, 31:14-21.
164. Williams G.D., Dardzinski B.J., Buckalew A.R., Smith M.B. Modest hypothermia preserves cerebral energy metabolism during hypoxia-ischemia and correlates with brain damage: a 31P nuclear magnetic resonance study in unanesthetized neonatal rats. Pediatr. Res. 1997, 42:700-708.
165. Woodward L.J., Edgin J.O., Thompson D., Inder T.E. Object working memory deficits predicted by early brain injury and development in the preterm infant. Brain 2005, 128:2578-2587.
166. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49:391-402.
167. Wu Y.W. Systematic review of chorioamnionitis and cerebral palsy. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:25.
168. Yan E., Castillo-Melendez M., Nicholls T., Hirst J., Walker D. Cerebrovascular responses in the fetal sheep brain to low-dose endotoxin. Pediatr. Res. 2004, 55:855-863.
169. Yang G.Y., Gong C., Qin Z., Liu X.H., Betz A.L. Tumour necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res. Mol. Brain. Res. 1999, 69:135-143.
170. Yawno T., Hirst J.J., Castillo-Melendez M., Walker D.W. Role of neurosteroids in regulating cell death and proliferation in the late gestation fetal brain. Neuroscience 2009, 163:838-847.
171. Yoon B.H., Jun J.K., Romero R., Park K.H., Gomez R., Choi J.H., et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am. J. Obstet. Gynecol. 1997, 177:19-26.
172. Yoon B.H., Romero R., Park J.S., Kim C.J., Kim S.H., Choi J.H., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am. J. Obstet. Gynecol. 2000, 182:675-681.
173. Yoon B.H., Romero R., Yang S.H., Jun J.K., Kim I.O., Choi J.H., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am. J. Obstet. Gynecol. 1996, 174:1433-1440.
174. Zhou W.-h., Cheng G.-q., Shao X.-m., Liu X.-z., Shan R.-b., Zhuang D.-y., et al. Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in china. J. Pediatr. 2010, 157:367-372.
175. Zhu C., Kang W., Xu F., Cheng X., Zhang Z., Jia L., et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009, 124:e218-e226.
176. Zhu S., Li M., Figueroa B.E., Liu A., Stavrovskaya I.G., Pasinelli P., et al. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J. Neurosci. 2004, 24:5909-5912.